European Association of Urology Guidelines on the Diagnosis and Treatment of Urolithiasis

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F26068877%3A_____%2F25%3AN0000032" target="_blank" >RIV/26068877:_____/25:N0000032 - isvavai.cz</a>

Výsledek na webu

<a href="https://www.sciencedirect.com/science/article/pii/S0302283825001812?via%3Dihub" target="_blank" >https://www.sciencedirect.com/science/article/pii/S0302283825001812?via%3Dihub</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1016/j.eururo.2025.03.011" target="_blank" >10.1016/j.eururo.2025.03.011</a>

Jazyk výsledku

angličtina

Název v původním jazyce

European Association of Urology Guidelines on the Diagnosis and Treatment of Urolithiasis

Popis výsledku v původním jazyce

Background and objective: The European Association of Urology urolithiasis guidelines provide evidence-based recommendations for the diagnosis and treatment of urinary stone disease. Given the complexity and variability of stone formation, individualised patient management is emphasised. Methods: The guidelines incorporate evidence from the latest research and focus on risk assessment, imaging techniques, pharmacological management, and surgical interventions. A research librarian conducted literature searches for urolithiasis in the Cochrane Library, Medline, and Embase databases via Dialog-Datastar. The strength of recommendations is also rated. Key findings and limitations: Diagnosis relies on a combination of clinical history, biochemical evaluation, and imaging, with ultrasound as the first-line modality and low-dose computed tomography as the gold standard for precise stone assessment. Stone composition and burden influence treatment decisions with algorithms primarily based on stone size, location, and composition. Nonsteroidal antiinflammatory drugs are recommended for first-line pain management, with opioids reserved as a secondary option. Medical expulsive therapy with a-blockers may be considered for selected patients with ureteral stones. Extracorporeal shockwave lithotripsy, ureteroscopy, and percutaneous nephrolithotomy remain the primary intervention modalities, with selection based on stone characteristics and patient ing is recommended for high-risk patients to guide personalised treatment. Conclusions and clinical implications: The guidelines provide a framework for clinical decision-making while acknowledging the need for continued advances in urolithiasis. (c) 2025 European Association of Urology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

Název v anglickém jazyce

European Association of Urology Guidelines on the Diagnosis and Treatment of Urolithiasis

Popis výsledku anglicky

Background and objective: The European Association of Urology urolithiasis guidelines provide evidence-based recommendations for the diagnosis and treatment of urinary stone disease. Given the complexity and variability of stone formation, individualised patient management is emphasised. Methods: The guidelines incorporate evidence from the latest research and focus on risk assessment, imaging techniques, pharmacological management, and surgical interventions. A research librarian conducted literature searches for urolithiasis in the Cochrane Library, Medline, and Embase databases via Dialog-Datastar. The strength of recommendations is also rated. Key findings and limitations: Diagnosis relies on a combination of clinical history, biochemical evaluation, and imaging, with ultrasound as the first-line modality and low-dose computed tomography as the gold standard for precise stone assessment. Stone composition and burden influence treatment decisions with algorithms primarily based on stone size, location, and composition. Nonsteroidal antiinflammatory drugs are recommended for first-line pain management, with opioids reserved as a secondary option. Medical expulsive therapy with a-blockers may be considered for selected patients with ureteral stones. Extracorporeal shockwave lithotripsy, ureteroscopy, and percutaneous nephrolithotomy remain the primary intervention modalities, with selection based on stone characteristics and patient ing is recommended for high-risk patients to guide personalised treatment. Conclusions and clinical implications: The guidelines provide a framework for clinical decision-making while acknowledging the need for continued advances in urolithiasis. (c) 2025 European Association of Urology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30217 - Urology and nephrology

Projekt

—

Návaznosti

N - Vyzkumna aktivita podporovana z neverejnych zdroju

Rok uplatnění

2025

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

EUROPEAN UROLOGY

ISSN

0302-2838

e-ISSN

1873-7560

Svazek periodika

88

Číslo periodika v rámci svazku

1

Stát vydavatele periodika

NL - Nizozemsko

Počet stran výsledku

12

Strana od-do

64-75

Kód UT WoS článku

001513127500016

EID výsledku v databázi Scopus

2-s2.0-105003288230